
Benny Quoc Tieu
Supervisory Patent Examiner (ID: 2443, Phone: (571)272-7490 , Office: P/2674 )
| Most Active Art Unit | 2642 |
| Art Unit(s) | 2614, 2642, 2625, 2742, 2674, 2682 |
| Total Applications | 759 |
| Issued Applications | 578 |
| Pending Applications | 87 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17822674
[patent_doc_number] => 11427612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Epimerization-free N to C solid-phase peptide synthesis
[patent_app_type] => utility
[patent_app_number] => 16/546549
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 67
[patent_no_of_words] => 20966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546549 | Epimerization-free N to C solid-phase peptide synthesis | Aug 20, 2019 | Issued |
Array
(
[id] => 16932427
[patent_doc_number] => 20210198316
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-07-01
[patent_title] => MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/539947
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 161200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -132
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16539947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/539947 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | Aug 12, 2019 | Abandoned |
Array
(
[id] => 16932427
[patent_doc_number] => 20210198316
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-07-01
[patent_title] => MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/539947
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 161200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -132
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16539947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/539947 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | Aug 12, 2019 | Abandoned |
Array
(
[id] => 18355084
[patent_doc_number] => 11643474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Peptide fusion protein
[patent_app_type] => utility
[patent_app_number] => 17/264577
[patent_app_country] => US
[patent_app_date] => 2019-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9479
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264577 | Peptide fusion protein | Jul 31, 2019 | Issued |
Array
(
[id] => 16977632
[patent_doc_number] => 20210221869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => FUSION PROTEIN COMPRISING THYROTROPIN RECEPTOR VARIANTS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/256296
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256296 | Fusion protein comprising thyrotropin receptor variants and use thereof | Jul 23, 2019 | Issued |
Array
(
[id] => 15083507
[patent_doc_number] => 20190336564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING TRANSPORT OF A DRUG
[patent_app_type] => utility
[patent_app_number] => 16/516811
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516811 | Methods and compositions for modulating transport of a drug | Jul 18, 2019 | Issued |
Array
(
[id] => 16413289
[patent_doc_number] => 10821151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Compositions and methods for treating cancer and persistent viral infections
[patent_app_type] => utility
[patent_app_number] => 16/512329
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 13852
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512329 | Compositions and methods for treating cancer and persistent viral infections | Jul 14, 2019 | Issued |
Array
(
[id] => 17052200
[patent_doc_number] => 20210261634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => LIGHT-INDUCIBLE PROTEIN AGGREGATION SYSTEM FOR MODELING PROTEINOPATHIES AND NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/252323
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252323 | Light-inducible protein aggregation system for modeling proteinopathies and neurodegenerative disorders | Jul 2, 2019 | Issued |
Array
(
[id] => 17905513
[patent_doc_number] => 11459357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Polymyxin compounds
[patent_app_type] => utility
[patent_app_number] => 17/253426
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21561
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253426 | Polymyxin compounds | Jun 24, 2019 | Issued |
Array
(
[id] => 16703193
[patent_doc_number] => 10953107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Polypeptide compositions and methods for site-specific targeting of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 16/441208
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 59
[patent_no_of_words] => 35986
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16441208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/441208 | Polypeptide compositions and methods for site-specific targeting of therapeutic agents | Jun 13, 2019 | Issued |
Array
(
[id] => 18604678
[patent_doc_number] => 11746128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Compositions and methods for increasing the immunoglobulin binding capacities of immunoglobulin-binding polypeptides and oligopeptides
[patent_app_type] => utility
[patent_app_number] => 16/438888
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 8658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438888 | Compositions and methods for increasing the immunoglobulin binding capacities of immunoglobulin-binding polypeptides and oligopeptides | Jun 11, 2019 | Issued |
Array
(
[id] => 17052187
[patent_doc_number] => 20210261621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Preparation of Dilipid Polymixins and Use Thereof as Antimicrobial Adjuvants
[patent_app_type] => utility
[patent_app_number] => 16/972700
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972700 | Preparation of Dilipid Polymixins and Use Thereof as Antimicrobial Adjuvants | Jun 4, 2019 | Abandoned |
Array
(
[id] => 16962909
[patent_doc_number] => 20210214408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
[patent_app_type] => utility
[patent_app_number] => 17/058884
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058884 | TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR | May 29, 2019 | Abandoned |
Array
(
[id] => 17052176
[patent_doc_number] => 20210261610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHOD FOR PRODUCING AMIDE
[patent_app_type] => utility
[patent_app_number] => 17/252053
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252053 | METHOD FOR PRODUCING AMIDE | May 27, 2019 | Abandoned |
Array
(
[id] => 17007065
[patent_doc_number] => 20210238226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/056566
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -167
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056566 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | May 21, 2019 | Abandoned |
Array
(
[id] => 15267435
[patent_doc_number] => 20190382451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => ZIKA AS A CELL PENETRATING PEPTIDE FOR DELIVERY TO THE BRAIN
[patent_app_type] => utility
[patent_app_number] => 16/405745
[patent_app_country] => US
[patent_app_date] => 2019-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16405745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/405745 | Zika as a cell penetrating peptide for delivery to the brain | May 6, 2019 | Issued |
Array
(
[id] => 15209783
[patent_doc_number] => 20190367578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => GIP DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/403241
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403241 | GIP derivatives and uses thereof | May 2, 2019 | Issued |
Array
(
[id] => 16831017
[patent_doc_number] => 11007248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Suppression of allergic lung inflammation and hyperreactivity
[patent_app_type] => utility
[patent_app_number] => 16/395030
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 26982
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395030 | Suppression of allergic lung inflammation and hyperreactivity | Apr 24, 2019 | Issued |
Array
(
[id] => 16969370
[patent_doc_number] => 11065317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Heat shock protein-binding peptide compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/394812
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 35002
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394812 | Heat shock protein-binding peptide compositions and methods of use thereof | Apr 24, 2019 | Issued |
Array
(
[id] => 16518705
[patent_doc_number] => 10869907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Implantable meshes for controlling the movement of fluids
[patent_app_type] => utility
[patent_app_number] => 16/394990
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394990 | Implantable meshes for controlling the movement of fluids | Apr 24, 2019 | Issued |